» Articles » PMID: 38441306

Nomograms to Predict Long-term Survival for Patients with Gallbladder Carcinoma After Resection

Overview
Specialty Oncology
Date 2024 Mar 5
PMID 38441306
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgical resection remains the primary treatment option for gallbladder carcinoma (GBC). However, there is a pressing demand for prognostic tools that can refine patients' treatment choices and tailor personalized therapies accordingly.

Aims: The nomograms were constructed using the data of a training cohort (n = 378) of GBC patients at Eastern Hepatobiliary Surgery Hospital (EHBH) between 2008 and 2018. The model's performance was validated in GBC patients (n = 108) at Guangzhou Centre from 2007 to 2018.

Methods And Results: The 5-year overall survival (OS) rate in the training cohort was 24.4%. Multivariate analyses were performed using preoperative and postoperative data to identify independent predictors of OS. These predictors were then incorporated into preoperative and postoperative nomograms, respectively. The C-index of the preoperative nomogram was 0.661 (95% CI, 0.627 to 0.694) for OS prediction and correctly delineated four subgroups (5-year OS rates: 48.1%, 19.0%, 15.6%, and 8.1%, p < 0.001). The C-index of the postoperative nomogram was 0.778 (95%CI, 0.756 -0.800). Furthermore, this nomogram was superior to the 8th TNM system in both C-index and the net benefit on decision curve analysis. The results were externally validated.

Conclusion: The two nomograms showed an optimally prognostic prediction in GBC patients after curative-intent resection.

Citing Articles

Newer Biomarkers in Gallbladder Carcinoma: A Scoping Review.

Upadhyay A, Nag D, Jena S, Sinha N, Lodh D Cureus. 2025; 16(12):e75142.

PMID: 39759612 PMC: 11700022. DOI: 10.7759/cureus.75142.


Prognostic evaluation in gallbladder carcinoma: Introducing a composite risk model integrating nutritional and immune markers.

Yang S, Zou R, Dai Y, Hu H, Li F Biomol Biomed. 2024; 25(2):425-435.

PMID: 39067064 PMC: 11734823. DOI: 10.17305/bb.2024.10673.


Nomograms to predict long-term survival for patients with gallbladder carcinoma after resection.

Bai S, Yang P, Qiu J, Wang J, Liu L, Wang C Cancer Rep (Hoboken). 2024; 7(3):e1991.

PMID: 38441306 PMC: 10913079. DOI: 10.1002/cnr2.1991.

References
1.
Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K . Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol. 2010; 17(7):1831-40. DOI: 10.1245/s10434-009-0899-1. View

2.
Aloia T, Jarufe N, Javle M, Maithel S, Roa J, Adsay V . Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015; 17(8):681-90. PMC: 4527853. DOI: 10.1111/hpb.12444. View

3.
Wen Z, Si A, Yang J, Yang P, Yang X, Liu H . Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma. HPB (Oxford). 2017; 19(11):951-956. DOI: 10.1016/j.hpb.2017.06.011. View

4.
Vickers A, Elkin E . Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006; 26(6):565-74. PMC: 2577036. DOI: 10.1177/0272989X06295361. View

5.
Are C . Common controversies in the management of gallbladder cancer. J Natl Compr Canc Netw. 2014; 12(5 Suppl):833-5. DOI: 10.6004/jnccn.2014.0201. View